drugset
drugset / Trial / NCT06137911

Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults.

NCT06137911 ↗

Phase 1 Completed 94 enrolled Guangzhou JOYO Pharma Co., Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical trial is to evaluate the safety, tolerability and pharmacokinetic characteristics of JYP0061 in healthy adult subjects. The main questions it aims to answer are: safety and tolerability of JYP0061 in healthy subjects, the pharmacokinetic characteristics after single and multiple doses and the effect of food on the pharmacokinetic characteristics. Participants will be treated with JYP0061 orally and safety and pharmacokinetic evaluations will be conducted according to the protocol.

Timeline

Start
2021-09-26
Primary completion
2022-11-09
Completion
2022-11-09

Drugs

EvaluationDrugModalityDoseRoute
Subject JYP0061 Unknown 15 mg Oral
Subject JYP0061 Unknown 30 mg Oral

Indications

No indication recorded.